Literature DB >> 20690646

Synthesis and characterization of nitroimidazole derivatives for 68Ga-labeling and testing in tumor xenografted mice.

Lathika Hoigebazar1, Jae Min Jeong, Soo Young Choi, Jae Yeon Choi, Dinesh Shetty, Yun-Sang Lee, Dong Soo Lee, June-Key Chung, Myung Chul Lee, Young Keun Chung.   

Abstract

Radiolabeled nitroimidazole (NI) derivatives have been used for imaging hypoxic tissues. We synthesized NI derivatives conjugated with bifunctional chelating agents such as 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) and isothiocyanatobenzyl-NOTA (SCN-NOTA) via ethyleneamine bridge by formation of amide and thiourea bond, respectively. We proved that amide oxygen of Ga-NOTA-NI contributes to the formation of metal complex by X-ray crystallography. We labeled them with (68)Ga and found that both (68)Ga-NOTA-NI and (68)Ga- SCN-NOTA-NI were labeled in high efficiency (>96%) and were stable at room temperature in the prepared medium and at 37 degrees C in human serum. In vitro cell uptake experiments using CHO and CT-26 cell lines showed significantly increased uptakes of both of the agents in hypoxic condition. Biodistribution study in CT-26 xenografted mice showed increasing tumor to muscle ratios. (68)Ga-NOTA-NI showed lower intestine uptake than (68)Ga-NOTA-SCN-NI due to hydrophilicity. Also, (68)Ga-NOTA-NI showed higher tumor uptake than (68)Ga-NOTA-SCN-NI in an animal PET study. In conclusion, we successfully developed (68)Ga labeled NI derivatives for hypoxic tissue imaging.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20690646     DOI: 10.1021/jm100545a

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Development of hypoxia enhanced 111In-labeled Bombesin conjugates: design, synthesis, and in vitro evaluation in PC-3 human prostate cancer.

Authors:  Nilesh K Wagh; Zhengyuan Zhou; Sunny M Ogbomo; Wen Shi; Susan K Brusnahan; Jered C Garrison
Journal:  Bioconjug Chem       Date:  2012-02-16       Impact factor: 4.774

Review 2.  An overview of the developments and potential applications of 68Ga-labelled PET/CT hypoxia imaging.

Authors:  Philippa L Bresser; Mariza Vorster; Mike M Sathekge
Journal:  Ann Nucl Med       Date:  2021-01-05       Impact factor: 2.668

Review 3.  (68)Ga-labeled radiopharmaceuticals for positron emission tomography.

Authors:  Dinesh Shetty; Yun-Sang Lee; Jae Min Jeong
Journal:  Nucl Med Mol Imaging       Date:  2010-10-12

4.  Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency.

Authors:  Ajay N Singh; Wei Liu; Guiyang Hao; Amit Kumar; Anjali Gupta; Orhan K Öz; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Bioconjug Chem       Date:  2011-07-26       Impact factor: 4.774

Review 5.  PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Authors:  Egesta Lopci; Ilaria Grassi; Arturo Chiti; Cristina Nanni; Gianfranco Cicoria; Luca Toschi; Cristina Fonti; Filippo Lodi; Sandro Mattioli; Stefano Fanti
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

Review 6.  Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.

Authors:  Sonja Stieb; Afroditi Eleftheriou; Geoffrey Warnock; Matthias Guckenberger; Oliver Riesterer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-20       Impact factor: 9.236

Review 7.  KSNM60: The History of Radiopharmaceutical Sciences in Korea.

Authors:  Ran Ji Yoo; Yun-Sang Lee; Kyo Chul Lee; Dong Wook Kim; Dong-Yeon Kim; Yearn Seong Choe; Jae Min Jeong
Journal:  Nucl Med Mol Imaging       Date:  2022-04-05

8.  GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo.

Authors:  Praveen K Gulaka; Federico Rojas-Quijano; Zoltan Kovacs; Ralph P Mason; A Dean Sherry; Vikram D Kodibagkar
Journal:  J Biol Inorg Chem       Date:  2013-11-27       Impact factor: 3.358

9.  In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.

Authors:  Choong Mo Kang; Sung-Min Kim; Hyun-Jung Koo; Min Su Yim; Kyung-Han Lee; Eun Kyoung Ryu; Yearn Seong Choe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-25       Impact factor: 9.236

10.  Stroma targeting nuclear imaging and radiopharmaceuticals.

Authors:  Dinesh Shetty; Jae-Min Jeong; Hyunsuk Shim
Journal:  Int J Mol Imaging       Date:  2012-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.